As the chill in the air intensifies, healthcare systems worldwide brace themselves for a seasonal upswing in respiratory illnesses. This year, the situation is exacerbated by the continuing threat of COVID-19 alongside the potential resurgence of seasonal influenza (Flu A and Flu B).
In the setting of a global pandemic, the specter of SARS-CoV-2 infection has understandably dominated the differential diagnosis for respiratory symptoms. However, it is crucial to remember that other respiratory pathogens continue to circulate, potentially leading to varied clinical presentations in patients who share the same exposure or living environment.
CME on-demand webinar presented by ASHA | A comprehensive guide for the detection and management of the often neglected sexually transmitted infection, Trichomoniasis.
As we move into the post-public health emergency landscape with the expiration of the national emergency concerning the coronavirus disease 2019 (COVID-19) pandemic on May 11, 2023, it is essential to understand how the healthcare industry has adapted and evolved to address the unique challenges posed by the COVID-19 pandemic.
Visby Medical™ announced today that it has received 510(k) clearance and was granted a CLIA waiver from the FDA for its 2nd generation point of care (POC) test.
Visby Medical announced today that it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration for its Respiratory Health point of care test.
Patients can now get results from PCR tests the same day thanks to new testing choices like Visby.
Visby Medical will exhibit at the 14th Annual ConvUrgent Care Symposium. Since 2008, this conference has gathered healthcare leaders into a community around the increasing consumerization of medical care.
Trichomoniasis, commonly known as “trich,” is one of the most common sexually transmitted infections (STIs). It is caused by a one-celled parasite, Trichomonas vaginalis. Men and women are affected by this infection, but it occurs more often in women.
Watch video highlights from “The Neglected Epidemic: A Panel Discussion about the Value Rapid POC PCR brings to Reproductive Health” panel discussion at the 2022 IDSOG Annual Meeting.